NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MyavA.10611.a: Alcohol dehydrogenase B

Target Characteristics

from organism: Mycobacterium avium 104
most recent status: expressed
center reference id: MyavA.10611.a
is community request: False
associated disease: Johne's disease, paratuberculosis
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyavA.10611.a.A1.GE29167 Full length( MyavA.10611.a ) 1 375 GE29167
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

External Resources

Resource Reference ID
OrthoMCL: OG5_127257
PATRIC ID: fig|243243.7.peg.684
RefSeq: YP_879981.1
UniProt: A0A0H2ZXU2

Enzyme & Pathway Information

Pathway Pathway ID EC Number
ethanol degradation I ETOH-ACETYLCOA-ANA-PWY 1.1.1.1
mixed acid fermentation FERMENTATION-PWY 1.1.1.1
heterolactic fermentation P122-PWY 1.1.1.1
acetylene degradation (anaerobic) P161-PWY 1.1.1.1
superpathway of N-acetylneuraminate degradation P441-PWY 1.1.1.1
hexitol fermentation to lactate, formate, ethanol and acetate P461-PWY 1.1.1.1
D-camphor degradation P601-PWY 1.1.1.1
ethanolamine utilization PWY0-1477 1.1.1.1
L-tryptophan degradation V (side chain pathway) PWY-3162 1.1.1.1
L-tyrosine degradation III PWY3O-4108 1.1.1.1
superpathway of fermentation (Chlamydomonas reinhardtii) PWY4LZ-257 1.1.1.1
L-valine degradation II PWY-5057 1.1.1.1
L-leucine degradation III PWY-5076 1.1.1.1
L-isoleucine degradation II PWY-5078 1.1.1.1
L-phenylalanine degradation III PWY-5079 1.1.1.1
L-methionine degradation III PWY-5082 1.1.1.1
pyruvate fermentation to ethanol I PWY-5480 1.1.1.1
pyruvate fermentation to ethanol II PWY-5486 1.1.1.1
phenylethanol biosynthesis PWY-5751 1.1.1.1
acetoin degradation PWY-6028 1.1.1.1
serotonin degradation PWY-6313 1.1.1.1
acetaldehyde biosynthesis I PWY-6333 1.1.1.1
noradrenaline and adrenaline degradation PWY-6342 1.1.1.1
pyruvate fermentation to ethanol III PWY-6587 1.1.1.1
superpathway of Clostridium acetobutylicum solventogenic fermentation PWY-6594 1.1.1.1
superpathway of Clostridium acetobutylicum acidogenic and solventogenic fermentation PWY-6604 1.1.1.1
ethanol degradation II PWY66-21 1.1.1.1
phytol degradation PWY66-389 1.1.1.1
salidroside biosynthesis PWY-6802 1.1.1.1
3-methylbutanol biosynthesis (engineered) PWY-6871 1.1.1.1
(S)-propane-1,2-diol degradation PWY-7013 1.1.1.1
pyruvate fermentation to isobutanol (engineered) PWY-7111 1.1.1.1
chitin degradation to ethanol PWY-7118 1.1.1.1
superpathway of anaerobic sucrose degradation PWY-7345 1.1.1.1
butanol and isobutanol biosynthesis (engineered) PWY-7396 1.1.1.1
dehydrodiconiferyl alcohol degradation PWY-7557 1.1.1.1

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MKTKGALIWE FNQPWSIEEI EIGDPQAHEV KIQMEAAGMC HSDHHLVTGG IPMAGFPVLG GHEGAGIVTE VGPGVEDIAP GDHVVLSFIP SCGSCPTCQA GMRNLCDLGA GLLGGEAVSD GTFRIQARGQ NVYPMTLLGT FSPYMVVHRS SVVKIDPSIP FEVAALVGCG VTTGYGSAVR TADIRPGQDV AIVGVGGVGM AALQGAVNAG ARYIFAIDPV EWKRDQALKF GATHVYPDIM AAMAGMAEVT YGLMAHKVVV TVGELQGADV DNYLNITQKG GTCVLTAIGS LLDTNVTLNL AMLTLMQKNL QGTIFGGGNP QYDIPQLLSM YKAGKLNLDD MITRQYRLEQ INDGYQDMLD GKNIRGVIRY TDADR

NT Sequence
GTGAAGACAA AAGGCGCACT GATCTGGGAG TTCAACCAGC CCTGGTCCAT CGAGGAAATC GAGATCGGCG ACCCGCAAGC GCATGAGGTC AAGATCCAGA TGGAAGCGGC GGGCATGTGC CACTCCGACC ATCACCTCGT CACCGGCGGC ATCCCGATGG CCGGCTTCCC GGTGCTCGGC GGGCACGAGG GCGCGGGCAT CGTCACCGAG GTCGGCCCCG GCGTCGAGGA CATCGCCCCG GGCGACCACG TGGTGCTGTC GTTCATCCCG TCCTGCGGCT CGTGTCCGAC CTGCCAGGCG GGCATGCGCA ACCTGTGTGA CCTGGGTGCG GGTCTGCTGG GCGGCGAAGC GGTGTCCGAC GGGACCTTCC GCATCCAGGC CCGCGGCCAG AACGTCTACC CCATGACGCT GCTGGGCACG TTTTCTCCGT ACATGGTGGT GCACCGCAGC TCGGTGGTGA AGATCGACCC GTCGATCCCG TTCGAGGTGG CCGCGCTGGT CGGCTGCGGC GTCACCACCG GTTACGGGTC GGCGGTCCGC ACCGCCGACA TCCGGCCGGG CCAGGACGTC GCCATCGTCG GCGTCGGCGG CGTGGGCATG GCGGCGCTGC AGGGCGCGGT CAACGCCGGC GCCCGCTACA TCTTCGCGAT CGACCCGGTG GAGTGGAAGC GCGACCAGGC ACTGAAGTTC GGCGCCACCC ACGTCTACCC CGACATCATG GCCGCCATGG CCGGCATGGC CGAGGTGACC TACGGCCTGA TGGCCCACAA GGTCGTCGTC ACCGTGGGCG AGCTGCAGGG CGCCGACGTC GACAACTACC TGAACATCAC CCAGAAGGGC GGCACCTGCG TGCTGACCGC CATCGGCAGC CTGCTGGACA CCAACGTGAC GCTGAACCTG GCGATGCTGA CCCTGATGCA GAAGAATTTG CAGGGCACCA TCTTTGGTGG CGGCAACCCG CAGTACGACA TCCCGCAGCT GCTGTCGATG TACAAGGCCG GCAAGCTCAA CCTGGACGAC ATGATCACCC GCCAGTACCG GCTCGAGCAG ATCAACGACG GCTATCAGGA CATGTTGGAC GGCAAGAACA TTCGCGGCGT CATCCGCTAC ACCGACGCCG ACCGG

© 2022 Seattle Children's Research Institute. All rights reserved.